Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation

Clinical Transplantation

Volumn 10, Issue 6 II, 1996, Pages 663-667

  Nymann, Trine ^a   Shokouh Amiri, M Hosein ^a   Vera, Santiago R ^a   Riely, Caroline A ^a   Alloway, Rita R ^a   Gaber, A Osama ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

HBIG immunoprophylaxis; HBV DNA; Hepatitis B; Liver transplantation; Recurrence

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT INFECTION;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS, CHRONIC; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE;

EID: 0030448498     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. EASON JD, FREEMAN RB, ROHRER RJ, et al. Should liver transplantation be performed for patients with hepatitis B? Transplantation 1994: 57: 1588.
2. DEVLIN J, SMITH HM, O'GRADY JG, PORTMANN B, TAN KC, WILLIAMS R. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients. J Hepatol 1994: 21: 204.
3. SAMUEL D, MULLER R, ALEXANDER G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993: 329: 1842.
4. LAUCHART W, MULLER R, PICHLMAYE R. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transpl Proc 1987: 19: 4051.
5. TODO S, DEMETRIS AJ, VAN THIEL D, TEPERMAN L, FUNG JJ, STARZL TE. Orthtopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991: 13: 619.
6. WRIGHT HI, GAVALER JS, VAN THIEL DH. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992: 53:121.
7. KRUGER M, TILLMANN HL, TRAUTWEIN C. Treatment of hepatitis B virus reinfection after liver transplantation with famciclovir. Hepatology 1994: 20: 134. Abstract.
8. BAIN VG, SHAPIRO AMJ, MA M, et al. Prevention of hepatitis B recurrence after liver transplantation with lamivudine. Int Liver Transpl Soc 1995: 447. Abstract.
9. MULLER R, GUBERNATIS G. FARLE M, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991: 13: 90.
10. SHAPIRO CN. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993: 12: 433.
11. LAUCHART W, MULLER R, PICHLMAYR, R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transpl Proc 1987: 19: 2387.
12. MORA NP, KLINTMALM GB, POPLAWSKI SS, et al. Recurrence of hepatitis B after liver transplantation: Does hepatitis-B-immunoglobulin modify the recurrent disease? Transpl Proc 1990: 22: 1549.
13. KONIG V, HOPF U, NEUHAUS P, et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994: 58: 553.
14. SAMUEL D, BISMUTH A, MATHIEU D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991: 337: 813.
15. DIENSTAG JL, PERRILLO RP, SCHIFF ER, BARTHOLOMOW M, VICARY C. RUBIN M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995: 333: 1657.